Patent ID: 7309596

Claim:
An isolated monomer of a type II serine proteinase inhibitor comprising an amino acid sequence selected from the group consisting of: DRICTNCCAGTKGCKYFSDDGTFVCEGESDPRNPKACTLNCDPRIAYGVCPRS (SEQ ID NO: 15) or a truncated form thereof wherein at least one amino acid residue from the N-terminus and/or the C-terminus of SEQ ID NO: 15 is absent; DRICTNCCAGTKGCKYFSDDGTFVCEGESDPRNPKACPRNCDPRIAYGICPLA (SEQ ID NO:16) or a truncated form thereof wherein at least one amino acid residue from the N-terminus and/or the C-terminus of SEQ ID NO: 16 is absent; DRICTNCCAGKKGCKYFSDDGTFVCEGESDPKNPKACPRNCDGRIAYGICPLS (SEQ ID NO: 17) or a truncated form thereof wherein at least one amino acid residue from the N-terminus and/or the C-terminus of SEQ ID NO: 17 is absent; DRICTNCCAGKKGCKYFSDDGTFVCEGESDPKNPKACPRNCDGRIAYGICPLS (SEQ ID NO:18) or a truncated form thereof wherein at least one at least one amino acid residue from the N-terminus and/or the C-terminus of SEQ ID NO: 18 is absent; and DRICTNCCAGKKGCKYFSDDGTFVCEGESDPRNPKACPRNCDGRIAYGICPLS (SEQ ID NO:19) or a truncated form thereof wherein at least one at least one amino acid residue from the N-terminus and/or the C-terminus of SEQ ID NO: 19 is absent; wherein said truncated forms of SEQ ID NOS: 15-19 have a type II serine proteinase inhibitor activity.